The beneficial effects of SQ-LNSs on Hb appeared to be greater among studies that were conducted in countries with a high burden of anemia (>60%); greater beneficial effects of SQ-LNSs on anemia and iron status were observed among studies that provided SQ-LNSs with a higher dose of iron and for a longer duration. The gene discussed is GSTM1; the disease is anemia.